(NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of ...
When faced with operational or working capital requirements such as boosting your performance marketing budget or venturing ...
PARIS, Nov. 4, 2024 /PRNewswire/ -- Dechert has advised Poxel (Euronext: POXEL), a clinical-stage biopharmaceutical company, on its non-dilutive financing agreement with OrbiMed for US$50 million.